Official reprint from UpToDate®
www.uptodate.com ©2016 UpToDate®

The aging kidney

Andrew D Rule, MD, MSc
Richard J Glassock, MD, MACP
Section Editor
Gary C Curhan, MD, ScD
Deputy Editor
Albert Q Lam, MD


The aging kidney has become a topic of great interest in geriatric medicine and clinical nephrology. In 1999, glomerular filtration rate (GFR)-estimating equations started to replace serum creatinine for the evaluation of kidney function. Since that time, more and more older adults have been identified as having acute or chronic kidney disease (CKD), and the prevalence of diagnosed kidney disease in this population has increased. About half of adults over the age of 70 years now have a measured or estimated glomerular filtration rate (eGFR) <60 mL/min/1.73 m2, a threshold often used to diagnose CKD [1].

This higher prevalence of diagnosed CKD is not simply due to increased recognition of diseases that tend to cluster in older adults, such as antineutrophil cytoplasmic antibody (ANCA)-positive small-vessel vasculitis, amyloidosis, diabetic nephropathy, and tubulointerstitial disorders. Rather, much of the increased rate of CKD diagnoses in the elderly population results from the normal structural and functional changes that occur in the kidney with aging [2]. Many have argued that this increased recognition of CKD is a positive development and leads to better care in elderly populations [3]. Others have argued that this is a harmful development that has led to unnecessary labeling of far too many older patients as "diseased" without any proven clinical benefit [4].

This review describes the structural and functional changes in the kidney with normal aging and the clinical significance of these changes. Issues related to estimation of GFR, the definition of CKD, and evaluation of patients with CKD are discussed elsewhere. (See "Assessment of kidney function" and "Definition and staging of chronic kidney disease in adults" and "Diagnostic approach to the patient with subacute kidney injury in an outpatient setting".)


Aging is a natural and inevitable biological process that results in structural and functional changes in many organ systems. The kidney systematically loses function (eg, glomerular filtration rate [GFR]) with age. In addition to specific kidney diseases that are common in older adults, such as diabetic nephropathy, physiological senescence of the kidney occurs, even with healthy aging [2]. A similar process occurs in the lung, which systematically loses function (ie, forced expiratory volume in one second), even among "healthy" adults [5]. (See "Reference values for pulmonary function testing".)

It can sometimes be difficult to distinguish the structural and functional changes of a kidney affected by a specific preventable or treatable disease from those of a kidney undergoing the inevitable consequences of aging. However, even if the reduction in function is not preventable or treatable, senescent changes in the kidney are relevant and important to managing older patients. Specifically, loss of renal reserves with aging has the following clinical significance (see 'Clinical significance of the aging kidney' below):


Subscribers log in here

To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information or to purchase a personal subscription, click below on the option that best describes you:
Literature review current through: Sep 2016. | This topic last updated: Apr 15, 2016.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2016 UpToDate, Inc.
  1. Schaeffner ES, Ebert N, Delanaye P, et al. Two novel equations to estimate kidney function in persons aged 70 years or older. Ann Intern Med 2012; 157:471.
  2. Glassock RJ, Rule AD. The implications of anatomical and functional changes of the aging kidney: with an emphasis on the glomeruli. Kidney Int 2012; 82:270.
  3. KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int Suppl 2013; 3:1.
  4. Moynihan R, Glassock R, Doust J. Chronic kidney disease controversy: how expanding definitions are unnecessarily labelling many people as diseased. BMJ 2013; 347:f4298.
  5. Swanney MP, Ruppel G, Enright PL, et al. Using the lower limit of normal for the FEV1/FVC ratio reduces the misclassification of airway obstruction. Thorax 2008; 63:1046.
  6. Kasiske BL, Umen AJ. The influence of age, sex, race, and body habitus on kidney weight in humans. Arch Pathol Lab Med 1986; 110:55.
  7. Rule AD, Amer H, Cornell LD, et al. The association between age and nephrosclerosis on renal biopsy among healthy adults. Ann Intern Med 2010; 152:561.
  8. Martin JE, Sheaff MT. Renal ageing. J Pathol 2007; 211:198.
  9. Zhou X, Zoltona G, Silva F. Anatomical Changes in the Aging Kidney. In: The Aging Kidney in Health and Disease, Macias Nunez J, JS C, Oreopoulos D (Eds), Springer Science+Business Media, LLC, New York 2008. p.39.
  10. Wiggins JE, Goyal M, Sanden SK, et al. Podocyte hypertrophy, "adaptation," and "decompensation" associated with glomerular enlargement and glomerulosclerosis in the aging rat: prevention by calorie restriction. J Am Soc Nephrol 2005; 16:2953.
  11. Kubo M, Kiyohara Y, Kato I, et al. Risk factors for renal glomerular and vascular changes in an autopsy-based population survey: the Hisayama study. Kidney Int 2003; 63:1508.
  12. Nyengaard JR, Bendtsen TF. Glomerular number and size in relation to age, kidney weight, and body surface in normal man. Anat Rec 1992; 232:194.
  13. Hoy WE, Douglas-Denton RN, Hughson MD, et al. A stereological study of glomerular number and volume: preliminary findings in a multiracial study of kidneys at autopsy. Kidney Int Suppl 2003; :S31.
  14. Mancilla E, Avila-Casado C, Uribe-Uribe N, et al. Time-zero renal biopsy in living kidney transplantation: a valuable opportunity to correlate predonation clinical data with histological abnormalities. Transplantation 2008; 86:1684.
  15. Kappel B, Olsen S. Cortical interstitial tissue and sclerosed glomeruli in the normal human kidney, related to age and sex. A quantitative study. Virchows Arch A Pathol Anat Histol 1980; 387:271.
  16. Vazquez Martul E, Veiga Barreiro A. Importance of kidney biopsy in graft selection. Transplant Proc 2003; 35:1658.
  17. Kaplan C, Pasternack B, Shah H, Gallo G. Age-related incidence of sclerotic glomeruli in human kidneys. Am J Pathol 1975; 80:227.
  18. Darmady EM, Offer J, Woodhouse MA. The parameters of the ageing kidney. J Pathol 1973; 109:195.
  19. Hodgin JB, Bitzer M, Wickman L, et al. Glomerular Aging and Focal Global Glomerulosclerosis: A Podometric Perspective. J Am Soc Nephrol 2015; 26:3162.
  20. Kremers WK, Denic A, Lieske JC, et al. Distinguishing age-related from disease-related glomerulosclerosis on kidney biopsy: the Aging Kidney Anatomy study. Nephrol Dial Transplant 2015; 30:2034.
  21. Fulladosa X, Moreso F, Narváez JA, et al. Estimation of total glomerular number in stable renal transplants. J Am Soc Nephrol 2003; 14:2662.
  22. Tan JC, Busque S, Workeneh B, et al. Effects of aging on glomerular function and number in living kidney donors. Kidney Int 2010; 78:686.
  23. Tan JC, Workeneh B, Busque S, et al. Glomerular function, structure, and number in renal allografts from older deceased donors. J Am Soc Nephrol 2009; 20:181.
  24. Vikse BE, Irgens LM, Leivestad T, et al. Low birth weight increases risk for end-stage renal disease. J Am Soc Nephrol 2008; 19:151.
  25. White SL, Perkovic V, Cass A, et al. Is low birth weight an antecedent of CKD in later life? A systematic review of observational studies. Am J Kidney Dis 2009; 54:248.
  26. Reyes L, Mañalich R. Long-term consequences of low birth weight. Kidney Int Suppl 2005; :S107.
  27. Luyckx VA, Bertram JF, Brenner BM, et al. Effect of fetal and child health on kidney development and long-term risk of hypertension and kidney disease. Lancet 2013; 382:273.
  28. Hayslett JP, Kashgarian M, Epstein FH. Functional correlates of compensatory renal hypertrophy. J Clin Invest 1968; 47:774.
  29. Sigmon DH, Gonzalez-Feldman E, Cavasin MA, et al. Role of nitric oxide in the renal hemodynamic response to unilateral nephrectomy. J Am Soc Nephrol 2004; 15:1413.
  30. Thomson SC, Vallon V, Blantz RC. Kidney function in early diabetes: the tubular hypothesis of glomerular filtration. Am J Physiol Renal Physiol 2004; 286:F8.
  31. Abdi R, Slakey D, Kittur D, Racusen LC. Heterogeneity of glomerular size in normal donor kidneys: impact of race. Am J Kidney Dis 1998; 32:43.
  32. Herts BR, Sharma N, Lieber M, et al. Estimating glomerular filtration rate in kidney donors: a model constructed with renal volume measurements from donor CT scans. Radiology 2009; 252:109.
  33. Rule AD, Semret MH, Amer H, et al. Association of kidney function and metabolic risk factors with density of glomeruli on renal biopsy samples from living donors. Mayo Clin Proc 2011; 86:282.
  34. Elsherbiny HE, Alexander MP, Kremers WK, et al. Nephron hypertrophy and glomerulosclerosis and their association with kidney function and risk factors among living kidney donors. Clin J Am Soc Nephrol 2014; 9:1892.
  35. Goyal VK. Changes with age in the human kidney. Exp Gerontol 1982; 17:321.
  36. Gourtsoyiannis N, Prassopoulos P, Cavouras D, Pantelidis N. The thickness of the renal parenchyma decreases with age: a CT study of 360 patients. AJR Am J Roentgenol 1990; 155:541.
  37. Emamian SA, Nielsen MB, Pedersen JF, Ytte L. Kidney dimensions at sonography: correlation with age, sex, and habitus in 665 adult volunteers. AJR Am J Roentgenol 1993; 160:83.
  38. Glodny B, Unterholzner V, Taferner B, et al. Normal kidney size and its influencing factors - a 64-slice MDCT study of 1.040 asymptomatic patients. BMC Urol 2009; 9:19.
  39. Bax L, van der Graaf Y, Rabelink AJ, et al. Influence of atherosclerosis on age-related changes in renal size and function. Eur J Clin Invest 2003; 33:34.
  40. Johnson S, Rishi R, Andone A, et al. Determinants and functional significance of renal parenchymal volume in adults. Clin J Am Soc Nephrol 2011; 6:70.
  41. Jeon HG, Lee SR, Joo DJ, et al. Predictors of kidney volume change and delayed kidney function recovery after donor nephrectomy. J Urol 2010; 184:1057.
  42. Wang X, Vrtiska TJ, Avula RT, et al. Age, kidney function, and risk factors associate differently with cortical and medullary volumes of the kidney. Kidney Int 2014; 85:677.
  43. McLachlan MS. The ageing kidney. Lancet 1978; 2:143.
  44. Samuel T, Hoy WE, Douglas-Denton R, et al. Determinants of glomerular volume in different cortical zones of the human kidney. J Am Soc Nephrol 2005; 16:3102.
  45. Tauchi H, Tsuboi K, Okutomi J. Age changes in the human kidney of the different races. Gerontologia 1971; 17:87.
  46. Rao UV, Wagner HN Jr. Normal weights of human organs. Radiology 1972; 102:337.
  47. McLachlan M, Wasserman P. Changes in sizes and distensibility of the aging kidney. Br J Radiol 1981; 54:488.
  48. Eknoyan G. A clinical view of simple and complex renal cysts. J Am Soc Nephrol 2009; 20:1874.
  49. Rule AD, Sasiwimonphan K, Lieske JC, et al. Characteristics of renal cystic and solid lesions based on contrast-enhanced computed tomography of potential kidney donors. Am J Kidney Dis 2012; 59:611.
  50. Baert L, Steg A. Is the diverticulum of the distal and collecting tubules a preliminary stage of the simple cyst in the adult? J Urol 1977; 118:707.
  51. Ravine D, Gibson RN, Walker RG, et al. Evaluation of ultrasonographic diagnostic criteria for autosomal dominant polycystic kidney disease 1. Lancet 1994; 343:824.
  52. Lorenz EC, Lieske JC, Vrtiska TJ, et al. Clinical characteristics of potential kidney donors with asymptomatic kidney stones. Nephrol Dial Transplant 2011; 26:2695.
  53. Lindeman RD, Tobin J, Shock NW. Longitudinal studies on the rate of decline in renal function with age. J Am Geriatr Soc 1985; 33:278.
  54. Poggio ED, Rule AD, Tanchanco R, et al. Demographic and clinical characteristics associated with glomerular filtration rates in living kidney donors. Kidney Int 2009; 75:1079.
  55. Wetzels JF, Kiemeney LA, Swinkels DW, et al. Age- and gender-specific reference values of estimated GFR in Caucasians: the Nijmegen Biomedical Study. Kidney Int 2007; 72:632.
  56. Eriksen BO, Løchen ML, Arntzen KA, et al. Subclinical cardiovascular disease is associated with a high glomerular filtration rate in the nondiabetic general population. Kidney Int 2014; 86:146.
  57. Hollenberg NK, Fisher ND, McCullough ML. Flavanols, the Kuna, cocoa consumption, and nitric oxide. J Am Soc Hypertens 2009; 3:105.
  58. Hollenberg NK, Martinez G, McCullough M, et al. Aging, acculturation, salt intake, and hypertension in the Kuna of Panama. Hypertension 1997; 29:171.
  59. Hollenberg NK, Rivera A, Meinking T, et al. Age, renal perfusion and function in island-dwelling indigenous Kuna Amerinds of Panama. Nephron 1999; 82:131.
  60. Fliser D, Ritz E. Renal haemodynamics in the elderly. Nephrol Dial Transplant 1996; 11 Suppl 9:2.
  61. Barton M. Ageing as a determinant of renal and vascular disease: role of endothelial factors. Nephrol Dial Transplant 2005; 20:485.
  62. Hollenberg NK, Moore TJ. Age and the renal blood supply: renal vascular responses to angiotensin converting enzyme inhibition in healthy humans. J Am Geriatr Soc 1994; 42:805.
  63. Kielstein JT, Bode-Böger SM, Haller H, Fliser D. Functional changes in the ageing kidney: is there a role for asymmetric dimethylarginine? Nephrol Dial Transplant 2003; 18:1245.
  64. Hollenberg NK, Adams DF, Solomon HS, et al. Senescence and the renal vasculature in normal man. Circ Res 1974; 34:309.
  65. Fliser D, Franek E, Joest M, et al. Renal function in the elderly: impact of hypertension and cardiac function. Kidney Int 1997; 51:1196.
  66. Fliser D, Ritz E. Relationship between hypertension and renal function and its therapeutic implications in the elderly. Gerontology 1998; 44:123.
  67. Fliser D, Zeier M, Nowack R, Ritz E. Renal functional reserve in healthy elderly subjects. J Am Soc Nephrol 1993; 3:1371.
  68. Lew SW, Bosch JP. Effect of diet on creatinine clearance and excretion in young and elderly healthy subjects and in patients with renal disease. J Am Soc Nephrol 1991; 2:856.
  69. Daugirdas JT, Meyer K, Greene T, et al. Scaling of measured glomerular filtration rate in kidney donor candidates by anthropometric estimates of body surface area, body water, metabolic rate, or liver size. Clin J Am Soc Nephrol 2009; 4:1575.
  70. Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009; 150:604.
  71. Rule AD, Bailey KR, Schwartz GL, et al. For estimating creatinine clearance measuring muscle mass gives better results than those based on demographics. Kidney Int 2009; 75:1071.
  72. Rule AD, Gussak HM, Pond GR, et al. Measured and estimated GFR in healthy potential kidney donors. Am J Kidney Dis 2004; 43:112.
  73. Inker LA, Schmid CH, Tighiouart H, et al. Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med 2012; 367:20.
  74. Rule AD, Glassock RJ. GFR estimating equations: getting closer to the truth? Clin J Am Soc Nephrol 2013; 8:1414.
  75. Lafarge JC, Naour N, Clément K, Guerre-Millo M. Cathepsins and cystatin C in atherosclerosis and obesity. Biochimie 2010; 92:1580.
  76. Staun-Ram E, Miller A. Cathepsins (S and B) and their inhibitor Cystatin C in immune cells: modulation by interferon-β and role played in cell migration. J Neuroimmunol 2011; 232:200.
  77. Naour N, Fellahi S, Renucci JF, et al. Potential contribution of adipose tissue to elevated serum cystatin C in human obesity. Obesity (Silver Spring) 2009; 17:2121.
  78. Rule AD, Bailey KR, Lieske JC, et al. Estimating the glomerular filtration rate from serum creatinine is better than from cystatin C for evaluating risk factors associated with chronic kidney disease. Kidney Int 2013; 83:1169.
  79. Mathisen UD, Melsom T, Ingebretsen OC, et al. Estimated GFR associates with cardiovascular risk factors independently of measured GFR. J Am Soc Nephrol 2011; 22:927.
  80. Pavkov ME, Knowler WC, Hanson RL, et al. Comparison of serum cystatin C, serum creatinine, measured GFR, and estimated GFR to assess the risk of kidney failure in American Indians with diabetic nephropathy. Am J Kidney Dis 2013; 62:33.
  81. Bhavsar NA, Appel LJ, Kusek JW, et al. Comparison of measured GFR, serum creatinine, cystatin C, and beta-trace protein to predict ESRD in African Americans with hypertensive CKD. Am J Kidney Dis 2011; 58:886.
  82. Hallan SI, Matsushita K, Sang Y, et al. Age and association of kidney measures with mortality and end-stage renal disease. JAMA 2012; 308:2349.
  83. Tian Y, Riazi S, Khan O, et al. Renal ENaC subunit, Na-K-2Cl and Na-Cl cotransporter abundances in aged, water-restricted F344 x Brown Norway rats. Kidney Int 2006; 69:304.
  84. Epstein M. Aging and the kidney. J Am Soc Nephrol 1996; 7:1106.
  85. Kaysen GA, Myers BD. The aging kidney. Clin Geriatr Med 1985; 1:207.
  86. Zhou XJ, Rakheja D, Yu X, et al. The aging kidney. Kidney Int 2008; 74:710.
  87. Esposito C, Dal Canton A. Functional changes in the aging kidney. J Nephrol 2010; 23 Suppl 15:S41.
  88. Combet S, Gouraud S, Gobin R, et al. Aquaporin-2 downregulation in kidney medulla of aging rats is posttranscriptional and is abolished by water deprivation. Am J Physiol Renal Physiol 2008; 294:F1408.
  89. Rodenburg EM, Hoorn EJ, Ruiter R, et al. Thiazide-associated hyponatremia: a population-based study. Am J Kidney Dis 2013; 62:67.
  90. Rule AD, Larson TS. Do we need another equation to estimate GFR from serum creatinine in renal allograft recipients? Nephrol Dial Transplant 2008; 23:2427.
  91. Pottel H, Hoste L, Delanaye P, et al. Demystifying ethnic/sex differences in kidney function: is the difference in (estimating) glomerular filtration rate or in serum creatinine concentration? Clin Chim Acta 2012; 413:1612.
  92. Pottel H, Vrydags N, Mahieu B, et al. Establishing age/sex related serum creatinine reference intervals from hospital laboratory data based on different statistical methods. Clin Chim Acta 2008; 396:49.
  93. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16:31.
  94. James MT, Hemmelgarn BR, Wiebe N, et al. Glomerular filtration rate, proteinuria, and the incidence and consequences of acute kidney injury: a cohort study. Lancet 2010; 376:2096.
  95. Gansevoort RT, Matsushita K, van der Velde M, et al. Lower estimated GFR and higher albuminuria are associated with adverse kidney outcomes. A collaborative meta-analysis of general and high-risk population cohorts. Kidney Int 2011; 80:93.
  96. Clase CM, Gao P, Tobe SW, et al. Estimated glomerular filtration rate and albuminuria as predictors of outcomes in patients with high cardiovascular risk: a cohort study. Ann Intern Med 2011; 154:310.
  97. Di Angelantonio E, Chowdhury R, Sarwar N, et al. Chronic kidney disease and risk of major cardiovascular disease and non-vascular mortality: prospective population based cohort study. BMJ 2010; 341:c4986.
  98. Drawz PE, Baraniuk S, Davis BR, et al. Cardiovascular risk assessment: addition of CKD and race to the Framingham equation. Am Heart J 2012; 164:925.
  99. Melander O, Newton-Cheh C, Almgren P, et al. Novel and conventional biomarkers for prediction of incident cardiovascular events in the community. JAMA 2009; 302:49.
  100. Fehrman-Ekholm I, Skeppholm L. Renal function in the elderly (>70 years old) measured by means of iohexol clearance, serum creatinine, serum urea and estimated clearance. Scand J Urol Nephrol 2004; 38:73.
  101. Tangri N, Stevens LA, Griffith J, et al. A predictive model for progression of chronic kidney disease to kidney failure. JAMA 2011; 305:1553.
  102. O'Hare AM, Choi AI, Bertenthal D, et al. Age affects outcomes in chronic kidney disease. J Am Soc Nephrol 2007; 18:2758.
  103. Fehrman-Ekholm I, Nordén G, Lennerling A, et al. Incidence of end-stage renal disease among live kidney donors. Transplantation 2006; 82:1646.
  104. Ibrahim HN, Foley R, Tan L, et al. Long-term consequences of kidney donation. N Engl J Med 2009; 360:459.
  105. Berger JC, Muzaale AD, James N, et al. Living kidney donors ages 70 and older: recipient and donor outcomes. Clin J Am Soc Nephrol 2011; 6:2887.
  106. Mjøen G, Hallan S, Hartmann A, et al. Long-term risks for kidney donors. Kidney Int 2014; 86:162.
  107. Davis CL, Delmonico FL. Living-donor kidney transplantation: a review of the current practices for the live donor. J Am Soc Nephrol 2005; 16:2098.
  108. Hallan SI, Dahl K, Oien CM, et al. Screening strategies for chronic kidney disease in the general population: follow-up of cross sectional health survey. BMJ 2006; 333:1047.
  109. Tanaka S, Takase H, Dohi Y, Kimura G. The prevalence and characteristics of microalbuminuria in the general population: a cross-sectional study. BMC Res Notes 2013; 6:256.
  110. Kestenbaum B, de Boer IH. Urine albumin-to-creatinine ratio: what's in a number? J Am Soc Nephrol 2010; 21:1243.
  111. Lambers Heerspink HJ, Gansevoort RT, Brenner BM, et al. Comparison of different measures of urinary protein excretion for prediction of renal events. J Am Soc Nephrol 2010; 21:1355.
  112. Fotheringham J, Campbell MJ, Fogarty DG, et al. Estimated albumin excretion rate versus urine albumin-creatinine ratio for the estimation of measured albumin excretion rate: derivation and validation of an estimated albumin excretion rate equation. Am J Kidney Dis 2014; 63:405.
  113. Ix JH, Wassel CL, Stevens LA, et al. Equations to estimate creatinine excretion rate: the CKD epidemiology collaboration. Clin J Am Soc Nephrol 2011; 6:184.
Topic Outline